CBD Archives | Cannabiz

‘Strong results’: Trial finds high-dose CBD reduced neuropathic pain

by Adam Sheldon June 2, 2026June 8, 2026

High-dose CBD reduced chronic neuropathic pain in a placebo-controlled clinical trial conducted by researchers from the […]

News in brief: Cannaponics raise tops $2.5m; Avecho receives $1.98m R&D incentive; Elixinol backs capital raising plans

by Adam Sheldon May 27, 2026June 8, 2026

The re-regulation of medicinal cannabis: is the TGA preparing to reassert control over THC?

by Dr Teresa Nicoletti May 18, 2026May 19, 2026

News in brief: Judgment reserved in CDA Clinics QLD legal case; Nexalis completes Phase 1 IRX-616a dosing

by Adam Sheldon May 18, 2026June 8, 2026

News in brief: Nexalis advances IRX-616a and IRX-211 programs; Vitura heralds Doctors on Demand growth; Elixinol improves cash flow

by Adam Sheldon April 20, 2026June 11, 2026

Survey of 239 patients suggests CBG may benefit pain, sleep and anxiety

by Adam Sheldon March 9, 2026March 10, 2026

Avecho prepares for potentially ‘transformative’ CBD trial results

by Adam Sheldon March 4, 2026June 8, 2026

Study traces how cannabis developed the ability to produce cannabinoids

by Adam Sheldon January 13, 2026June 8, 2026

News in brief: Avecho gains key patent allowances; Montu expands medical affairs team

by Adam Sheldon December 9, 2025February 21, 2026

Financial news in brief: Elixinol addresses funding concerns; Aurora growth helped by Australia; Avecho lifts cash, progresses trial; Cann receives NAB extension to finalise settlement; IRX reports lean quarter

by Adam Sheldon November 4, 2025February 21, 2026